Empowering the CRISPR/Cas9 platform globally

ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.

Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.

By loading the video, you agree to YouTube's privacy policy.
Learn more

Always unblock YouTube

Licenses are available in a wide range of fields

Internal
Research

Industrial Bio
Production

CRO’s
CMO’s

Tools /
Reagents